The support of referents in clinical and academic research
ELSALYS BIOTECH, located at the heart of the LYONBIOPOLE health cluster – a European centre of excellence in pharmaceutical research and industry – has developed a national and international network of referent partners in clinical and academic research, engaged in the development of innovative therapies. This includes Inserm, the Léon Bérard cancer centre (Lyon), the Curie Institute (Paris), DKFZ, German cancer research centre, the Barcelona Clinical Hospital, today engaged in the various ELSALYS BIOTECH research programmes.
This network of colllaborations involving top-class laboratories and experts is a key asset to:
- Enable the Company to identify, evaluate and acquire first-in-class therapeutic targets with innovative mechanisms of action and thus broaden its portfolio;
- Contribute to the development of ongoing programmes by evaluating the unmet medical needs and the related business opportunities;
- Accelerate the preclinical and clinical studies of programmes, with facilitated access to samples or patient cohorts, in an increasingly competitive environment.